Section Arrow
SLNO.NASDAQ
- Soleno Therapeutics
Quotes are at least 15-min delayed:2026/01/09 07:15 EST
Pre Market
Last
 45.8
+0.3 (+0.66%)
Bid
45
Ask
45.9
High 45.89 
Low 44.76 
Volume 383 
Regular Hours (Closed)
Last
 45.5
+1.11 (+2.50%)
Day High 
50.88 
Prev. Close
44.39 
1-M High
55.4676 
Volume 
2.89M 
Bid
45
Ask
45.9
Day Low
43.42 
Open
44.23 
1-M Low
43.88 
Market Cap 
2.38B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 46.87 
20-SMA 48.23 
50-SMA 50.92 
52-W High 90.3199 
52-W Low 41.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.75/7.20
Enterprise Value
2.44B
Balance Sheet
Book Value Per Share
9.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1033-0.0223-17.75%-- 
Pre Market 0.1017 -0.0016 -1.55%
ACRVAcrivon Therapeutics1.93-1.02-34.58%-- 
Pre Market 1.83 -0.1 -5.18%
VTYXVentyx Biosciences13.84+0.11+0.80%-- 
Pre Market 13.81 -0.03 -0.22%
MLTXMoonLake Immunotherapeutics14.34+3.05+27.02%-- 
Pre Market 14.95 +0.61 +4.25%
CRMDCorMedix7.51-3.66-32.77%5.05PE
Pre Market 7.57 +0.06 +0.80%
Industry overview quotes are at least 15 minutes delayed
Business Description
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.